Form 4: SpringWorks Therapeutics Chief Medical Officer Reports Stock Disposals for Tax Obligations
SEC Form 4 Filing
SpringWorks Therapeutics' Chief Medical Officer, James Cassidy, disposed of company stock to cover tax obligations related to vesting restricted stock units.
Summary
- James Cassidy, the Chief Medical Officer of SpringWorks Therapeutics, reported the disposal of company stock.
- The disposals were made on January 4th, 5th and 6th of 2025.
- These transactions were not sales by Mr. Cassidy, but rather shares withheld by the company to cover tax obligations related to the vesting of restricted stock units.
- A total of 9,448 shares were disposed of across the three days.
- The price per share was $38.19 on January 4th and 5th, and $38.86 on January 6th.
- Following these transactions, Mr. Cassidy beneficially owns 64,408 shares of SpringWorks Therapeutics stock.
Sentiment
Score: 7
Explanation: The document reflects a routine transaction for tax purposes, which is neither positive nor negative for the company's outlook. The sentiment is neutral to slightly positive as it indicates the executive is vested in the company.
Industry Context
This is a routine filing related to stock transactions by a company insider, which is common in publicly traded companies. It does not indicate any specific trend or issue within the pharmaceutical industry.
Comparison to Industry Standards
- Stock disposals for tax obligations are a common practice among executives in publicly traded companies, including those in the pharmaceutical sector.
- Similar filings are regularly seen from executives at companies like Pfizer, Moderna, and Johnson & Johnson, when they exercise stock options or have restricted stock units vest.
Stakeholder Impact
- The stock disposals are unlikely to have a significant impact on shareholders, as they are related to tax obligations and not a sale of shares by the executive.
- The transactions do not affect employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 01/04/2025 | Disposal of 4,325 shares at $38.19 per share. |
| 01/05/2025 | Disposal of 3,465 shares at $38.19 per share. |
| 01/06/2025 | Disposal of 1,658 shares at $38.86 per share. |
| 01/07/2025 | Date of signature for the Form 4 filing. |
Keywords
SpringWorks Therapeutics, stock disposal, insider trading, tax obligations, restricted stock units, SWTX, Chief Medical Officer, James Cassidy
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.